Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2025-12-25 @ 10:24 PM
NCT ID: NCT00474058
Description: Serious and non- serious Adverse Events (AEs) refer to the Safety Set (SS). The SS includes all subjects who are randomized and received at least one dose of trial medication.
Frequency Threshold: 5
Time Frame: Adverse Events (AEs) were collected up to 22 weeks from Visit 1 to the Safety Follow- Up Visit.
Study: NCT00474058
Study Brief: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Rotigotine Rotigotine transdermal patch None None 10 191 70 191 View
Placebo Placebo transdermal patch None None 5 96 21 96 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders MedDRA (9.1) View
Cholecystitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (9.1) View
Urosepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (9.1) View
Ankle fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (9.1) View
Intervertebral disc protrusion SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (9.1) View
Chronic lymphocytic leukaemia SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (9.1) View
Basal cell carcinoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (9.1) View
Cerebrovascular accident SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View
Abortion SYSTEMATIC_ASSESSMENT Pregnancy, puerperium and perinatal conditions MedDRA (9.1) View
Panic attack SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (9.1) View
Completed suicide SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (9.1) View
Hallucination, visual SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (9.1) View
Sleep attacks SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (9.1) View
Nephrotic syndrome SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (9.1) View
Renal impairment SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (9.1) View
Benign prostatic hyperplasia SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (9.1) View
Pneumonia aspiration SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (9.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View
Dyskinesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View